You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bempegaldesleukin

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)

Terminated
Has Results
  • Metastatic Head and Neck Cancer
  • Recurrent Head and Neck Cancer
  • Omaha, Nebraska
  • +3 more
Dec 16, 2022

Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)

Completed
  • Covid-19
  • Coronavirus Disease 2019
  • Bempegaldesleukin
  • +2 more
  • Hialeah, Florida
  • +3 more
Mar 31, 2022

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Renal Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer, Urothelial Carcinoma Trial in United States (XL092,

Recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Tucson, Arizona
  • +3 more
Mar 30, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022